Pomicell, a revolutionary global AI SaaS platform for Medical research and personalized medicine, announces and welcomes Mr. Gabriel Shachor as CEO effective immediately.
Mr. Shachor has over 30 years experience in founding and leading technological ventures from concept through defining vision and strategy, building the team and organization finances through his extensive experience in technological product development, production, developing the new product markets with global sales worth millions of dollars. Mr. Shachor brings to the company outstanding entrepreneurial and management capabilities in both small and large-scale organizations, as well as a thorough understanding of technologies and excellent interpersonal relations, which motivate the team towards achieving objectives.
Recommended AI News: Mushroom Supplement Label VidaCap Set to Release Rare, Collectible NFT’s on Ethereum Blockchain
Mr. Shachor will lead the company in launching its flagship AI Saas Platform solution geared at assisting biomedical professionals to accelerate research and propel drug development discovery forward. In addition, Mr. Shachor will be leading the company into an investment Round A for next generation product development and go to market in multiple territories around the globe.
“I am delighted to be part of such an innovative and creative team. Pomicell is rapidly growing and heading towards becoming a global leader in advanced AI technology for biomedical research & personalized medicine,” said Mr. Shachor. “I am looking forward to utilizing my experience to help project Pomicell forward and enable the company to meet future milestones for growth.”
Recommended AI News: DigiPlex Reinforces Customer Assurance with Successful Audits of ISO, SOC1 and IASE Certifications at All Eight Data Centers
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.